BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 11436958)

  • 1. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant medications in children.
    Vitiello B; Swedo S
    N Engl J Med; 2004 Apr; 350(15):1489-91. PubMed ID: 15071123
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
    Prescrire Int; 2004 Oct; 13(73):163-5. PubMed ID: 15499694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.
    DeVane CL; Sallee FR
    J Clin Psychiatry; 1996 Feb; 57(2):55-66. PubMed ID: 8591970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors in children and adolescents.
    Diler RS; Avci A
    Swiss Med Wkly; 2002 Aug; 132(33-34):470-7. PubMed ID: 12458447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
    Ravindran AV; Lapierre YD; Anisman H
    Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
    Murphy TK; Bengtson MA; Tan JY; Carbonell E; Levin GM
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S47-63. PubMed ID: 11110019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy.
    Rone LA; Ferrando SJ
    Psychosomatics; 1996; 37(2):165-6. PubMed ID: 8742546
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression: making the diagnosis and using SSRIs in the older patient.
    Reynolds CF
    Geriatrics; 1996 Oct; 51(10):28-34. PubMed ID: 8863755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
    Judge R; Parry MG; Quail D; Jacobson JG
    Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin re-uptake inhibitors for children and adolescents.
    Ziervogel CF
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I20-6. PubMed ID: 11140777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are SSRIs safe for children?
    Med Lett Drugs Ther; 2003 Jul; 45(1160):53-4. PubMed ID: 12840712
    [No Abstract]   [Full Text] [Related]  

  • 18. SSRIs: Prozac and company - part I.
    Harv Ment Health Lett; 2000 Oct; 17(4):1-3. PubMed ID: 11015755
    [No Abstract]   [Full Text] [Related]  

  • 19. Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?
    Safer DJ
    Pediatrics; 2006 Sep; 118(3):1248-51. PubMed ID: 16951019
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.
    Giner L; Nichols CM; Zalsman G; Oquendo MA
    Int J Adolesc Med Health; 2005; 17(3):211-20. PubMed ID: 16231472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.